Avinger Receives FDA Clearance of Pantheris SV Device
Avinger, Inc. (AVGR)
Last avinger, inc. earnings: 8/8 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.avinger.com
Company Research
Source: GlobeNewswire
REDWOOD CITY, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that the Company received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pantheris SV (Small Vessel) image-guided atherectomy system. Pantheris SV, a product line extension of Avinger’s Lumivascular image-guided atherectomy platform, is expected to expand the available market for Pantheris by up to 50% and allow the Company to address a larger portion of the estimated $500 million atherectomy market. Designed with a lower profile and longer length than Pantheris, Pantheris SV is indicated for the diagnosis and treatment of PAD in small vessels (2 to 4 millimeters in diameter). Pantheris SV incorporates key improvements introduced to the platform with the launch of the next-generation Pantheris system in June 20
Show less
Read more
Impact Snapshot
Event Time:
AVGR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVGR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVGR alerts
High impacting Avinger, Inc. news events
Weekly update
A roundup of the hottest topics
AVGR
News
- Avinger, Inc. (NASDAQ: AVGR) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Avinger, Inc. (NASDAQ: AVGR) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Avinger, Inc. (NASDAQ: AVGR) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Avinger, Inc. (NASDAQ: AVGR) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Avinger, Inc. (NASDAQ: AVGR) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
AVGR
Analyst Actions
- 3/21/24 - HC Wainwright
AVGR
Sec Filings
- 4/15/24 - Form EFFECT
- 4/12/24 - Form DEFA14A
- 4/12/24 - Form DEF
- AVGR's page on the SEC website